On January 4, 2022 CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory disease, reported that CorMedix management will be participating in several upcoming investor conferences in January (Press release, CorMedix, JAN 4, 2022, View Source [SID1234598063]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Investor Conference Details

LifeSci Partners – 11th Annual Corporate Access Event
Wednesday, January 5th – Friday, January 7th
To register and submit one-on-one meeting requests, Click Here

H.C. Wainwright Bioconnect Virtual Conference
Monday, January 10th – Thursday, January 13th
To register for the conference, Click Here

Biotech Showcase Virtual Conference
Monday, January 10th – Wednesday, January 12th
To register and submit one-on-one meeting requests, Click Here